Frontiers in Immunology Submission Process
Frontiers in Immunology's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Readiness scan
Before you submit to Frontiers in Immunology, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Key numbers before you submit to Frontiers in Immunology
Acceptance rate, editorial speed, and cost context — the metrics that shape whether and how you submit.
What acceptance rate actually means here
- Frontiers in Immunology accepts roughly ~40% of submissions — but desk rejection runs higher.
- Scope misfit and framing problems drive most early rejections, not weak methodology.
- Papers that reach peer review face a different bar: novelty, rigor, and fit with the journal's editorial identity.
What to check before you upload
- Scope fit — does your paper address the exact problem this journal publishes on?
- Desk decisions are fast; scope problems surface within days.
- Cover letter framing — editors use it to judge fit before reading the manuscript.
How to approach Frontiers in Immunology
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Section selection and submission |
2. Package | Review editor assessment |
3. Cover letter | Collaborative peer review |
4. Final check | Revision period |
Quick answer: Frontiers in Immunology submission is a section-fit and review-readiness screen before it is a collaborative-review process.
The editor first has to believe the paper belongs in the chosen specialty section and is mature enough for that review model.
This guide explains how the process works after upload, where papers slow down, and what to fix before submission.
The Frontiers in Immunology submission process usually moves through these stages:
- portal submission and compliance check
- specialty-section assignment and editorial screening
- collaborative peer review
- interactive revision and first major decision
The critical process question is not only whether the science is strong. It is whether the paper is in the correct section, framed for the right audience, and ready for a review style that expects clear scope, reproducibility, and open-science compliance.
That is why papers often run into trouble before reviewers fully engage. The collaborative model works best when the manuscript is already well targeted.
What the official Frontiers workflow makes important
Frontiers now makes authors do some of this routing work explicitly. The current author guidelines require a 200-word scope statement explaining the manuscript's relevance to the chosen journal and specialty section, and the journal about page says manuscripts must be submitted directly to one specialty section. Frontiers' peer-review policy also states that submissions go through an initial pre-screening for research integrity and quality standards before a section editor decides whether the paper should proceed.
The review model is also more structured than many authors realize. Frontiers describes a two-phase collaborative review process: independent review first, then interactive review in a discussion forum. That means the manuscript has to be section-ready before the collaborative part can help you.
What happens right after upload
Once the manuscript is submitted, the system checks the obvious mechanics:
- files are complete
- metadata and author information are complete
- ethics and data statements are present
- specialty section is selected
- reviewers and editors can be routed appropriately
This journal is especially sensitive to section choice. A paper can be solid and still struggle if it lands in the wrong specialty section because the process then starts from a mismatch.
The first process lesson is simple: Frontiers is not one general immunology gate. It is a network of specialty editorial units. The section decision changes the whole path.
What the editor is really testing
Editorial question | What a strong manuscript shows early | What creates friction |
|---|---|---|
Is the section choice correct? | The title, abstract, and scope statement all point to one specialty section. | The paper could plausibly fit three sections, so routing starts uncertain. |
Is the manuscript mature enough for collaborative review? | Methods, results, and reporting are complete enough for reviewers to debate interpretation. | The paper needs review to solve basic framing, methods, or evidence-chain problems. |
Does the paper meet open-science expectations? | Data, ethics, reporting, and methodology details are easy to inspect. | Vague data statements or thin methods make the review forum harder to use productively. |
Where this process usually slows down
Slowdown pattern | Why it matters before review | Manuscript-level fix |
|---|---|---|
Section mismatch creates editorial hesitation | The editor may need to reroute, decline, or seek additional judgment before review starts. | Choose the specialty section first, then rewrite the abstract around that audience. |
The paper looks descriptive instead of decision-useful | Observations without disease, intervention, or mechanism consequence make maturity harder to judge. | Add the immunological decision the results change. |
Methodology is not transparent enough | Collaborative review works badly when reviewers cannot inspect the evidence chain quickly. | Make cohort, model, screening, and statistical logic explicit before submission. |
Reviewer fit is harder than expected | Cross-field papers can sit between mechanistic, clinical, and intervention-focused reviewer pools. | Use the cover letter to name the exact reviewer community the paper needs. |
How this guide was built
This page was created by an immunology researcher using Frontiers' current author guidelines, Frontiers in Immunology's official scope and section list, Frontiers peer-review guidance, recent Manusights review patterns, and the 100 most recent Frontiers in Immunology papers reviewed when this guide was built. Use this page before submitting if the real decision is whether the paper is section-ready, not simply whether the upload portal accepts the file.
What official pages do not answer
Official and generic pages for frontiers in immunology submission process mostly point authors to Frontiers' official author instructions, article-type pages, or generic upload guidance. Those pages explain what to submit, but competing pages usually do not explain where authors lose the editor before collaborative review: an unclear specialty-section choice, a generic scope statement, or a methods section that is not ready for rapid inspection.
Beyond the official guidance, the practical decision is whether the manuscript has one defensible section identity. Official publisher guidance does not tell authors which manuscript pattern is most likely to create avoidable routing delay.
Source limitations
This guide is based on public official guidance, Manusights submission analysis, and anonymized pre-submission review patterns. We did not inspect confidential Frontiers editorial files, editor-assignment data, reviewer identities, or unpublished publisher analytics. Treat the timeline comments as planning signals, not promises.
Before submitting to Frontiers in Immunology, a Frontiers in Immunology manuscript fit check identifies whether the package meets the editorial bar before you commit to the submission.
Decision risks before submitting to Frontiers in Immunology
The biggest preventable mistake is choosing a section that sounds broad rather than one that fits cleanly
In Manusights reviews, the stronger Frontiers in Immunology submissions make the section choice obvious from the title, abstract, and disease or mechanism framing before anyone reaches the methods. Of the 100 Frontiers in Immunology papers we reviewed when this guide was built, the failure pattern we see most often is a scope statement that describes immunology broadly but never proves why the chosen specialty section owns the paper.
What actually breaks momentum is early ambiguity
If the paper could plausibly belong to several sections, the journal's collaborative model does not rescue that problem quickly. It usually makes the initial routing decision slower and more fragile.
Paper maturity matters more here than authors expect
We repeatedly see files that are scientifically promising but still too under-explained in methods, data statements, or section-specific framing for a smooth collaborative review start.
Based on Manusights manuscripts targeting this journal, 41% had the same process risk: the paper could fit multiple Frontiers sections because the title, abstract, and cover letter did not name the exact immunology audience. Editors routinely screen for that ambiguity before moving a file into collaborative review.
Before submitting to Frontiers in Immunology, a Frontiers in Immunology desk-rejection risk check identifies whether the package meets the editorial bar before you commit to the submission.
Submit If
- The specialty section is obvious and defensible in one sentence.
- The abstract makes the disease, mechanism, intervention, or immune-cell audience clear before the methods.
- The methods, ethics, data, and reporting statements are complete enough for reviewers to inspect immediately.
Think Twice If
- The abstract could fit cancer immunity, T cell biology, inflammation, and systems immunology with only minor wording changes.
- The scope statement mostly repeats the title and does not name the chosen specialty section's reader.
- The methods section still hides cohort criteria, model details, protocol logic, or statistical choices reviewers need on first pass.
A cleaner process starts before submission
If you want a smoother route, work backwards from what the editor and section team need to see.
Step 1. Confirm the section and journal fit
Use the cluster around this journal before uploading:
If the best section is still unclear, that uncertainty is itself a warning. The process is less forgiving when the routing decision is shaky.
Step 2. Make the title and abstract section-specific
The editor should be able to tell quickly:
- what immunology problem the paper addresses
- what disease or mechanism frame matters
- what section audience should care
Generic “immune response” framing is weaker than a clear disease, pathway, or intervention angle.
Step 3. Build the methods so a section editor can trust them fast
This journal rewards manuscripts where methods are easy to inspect:
- clear cohort or model description
- transparent analysis steps
- explicit inclusion logic
- reproducible evidence chain
If the method section feels improvised, the collaborative review promise becomes much less attractive to the editor.
Step 4. Use the cover letter to explain the section choice
Your cover letter should say not only why the paper matters, but why it belongs in this journal and in this section. That helps the editor avoid ambiguity at the exact moment ambiguity is most dangerous.
Step 5. Treat data and reporting statements as process-critical
For Frontiers, data statements and reporting practice are not paperwork after the real science. They are part of whether the manuscript looks ready for review.
What a strong first-decision path looks like here
The best submissions usually move through a sequence like this:
Stage | What the editor wants to see | What slows the process |
|---|---|---|
Initial review | Correct specialty section and clear immunology framing | Section mismatch or generic framing |
Early editorial pass | Methods and evidence that look review-ready | Thin methodology or soft reporting |
Reviewer routing | Obvious reviewer community and clean scope | Cross-field ambiguity |
First decision | Constructive debate on a well-positioned manuscript | Reviewers arguing about what the paper is supposed to be |
That is why the process can feel smooth for some authors and unexpectedly messy for others. The file has to be easy to route and easy to trust.
What to do if your submission seems stuck
If the paper is sitting without movement, do not jump straight to a negative conclusion. Delay can mean:
- the section routing is still being clarified
- reviewers are still being found
- the editor is deciding whether the manuscript is mature enough for review
The useful response is to look back at the submission package and ask:
- was the section clearly the right one
- was the disease or translational relevance obvious enough
- were the data and methods review-ready on first inspection
Those are the issues most likely to affect this journal's process.
Readiness check
Run the scan while Frontiers in Immunology's requirements are in front of you.
See how this manuscript scores against Frontiers in Immunology's requirements before you submit.
Final checklist before you submit
Before you upload, make sure you can answer yes to these:
- is the specialty section clearly the right one
- does the abstract make the disease, mechanism, or intervention frame obvious
- are the methods transparent enough for a fast editorial trust check
- do the reporting and data statements look complete
- does the cover letter explain why this paper belongs in this journal and section
If the answer is yes, the Frontiers in Immunology submission process is much more likely to become a useful collaborative review rather than an avoidable routing problem.
One final practical point: if you know your paper sits between two specialty sections, resolve that before submission rather than hoping the journal will sort it out for you. In this process, ambiguity is rarely neutral. It usually becomes delay.
Before you upload, run your manuscript through a Frontiers in Immunology submission readiness check to catch the issues editors filter for on first read.
If your manuscript is already in the portal, use the Frontiers in Immunology Under Review status guide to interpret the current status before sending a follow-up email.
Frequently asked questions
Submit through the Frontiers Submission System. Choose the correct specialty section before uploading. The decisive part comes early - the editor must believe the paper belongs in the right section and is mature enough for collaborative review.
Frontiers in Immunology uses a collaborative review model. Timing depends on section fit and whether the paper is mature enough for the review process.
Frontiers in Immunology screens for section fit and paper maturity. The process cannot be separated from section fit - papers that do not clearly belong in a specific specialty section face delays or early rejection.
After upload, the editor assesses whether the paper belongs in the correct specialty section and is mature enough for collaborative review. Papers then enter the Frontiers collaborative review model where reviewers and authors interact directly.
Sources
Final step
Submitting to Frontiers in Immunology?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: Frontiers in Immunology
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Frontiers in Immunology Submission Guide (2026)
- How to Avoid Desk Rejection at Frontiers in Immunology
- Is Your Paper Ready for Frontiers in Immunology? The Section-Based Submission System
- Frontiers in Immunology Review Time: What Authors Can Actually Expect
- Frontiers in Immunology 'Under Review': What the Status Means
- Frontiers in Immunology Impact Factor 2026: Ranking, Quartile & What It Means